CD44 and breast carcinoma: We found that the proportion of CD44+ MDA-MB-231 cells was ~12-folds higher in 3D hybrid scaffold compared to scaffold and GelMA alone, indicating that 3D hybrid scaffold strikingly influenced the phenotypic changes of breast cancer cells (Figs 5B–D, S4).